scholarly journals Prevalence of diabetes mellitus in rural population of Mullana, district Ambala, Haryana, India

Author(s):  
Nitesh Pradhan ◽  
Abhishek Sachdeva ◽  
Tushar Goel ◽  
Sahil Arora ◽  
Shekhar Barua

Background: Diabetes mellitus (DM) is a major cause of avoidable blindness in developing and developed countries. The International Diabetes Federation (IDF)’s Diabetes Atlas reports that India has the highest number of people with diabetes (nearly 25%) in the world, and hence considered to be the “Diabetes Capital of the World”.Methods: This is a hospital record based study was planned to estimate the prevalence of Diabetes Mellitus in various age groups in rural population of Mullana, District Ambala(Haryana).Results: Out of 1050 patients screened 50 were found to be having Diabetes mellitus (DM) 1000 were non-diabetic i.e. prevalence of Diabetes mellitus (DM) was found to be 4.76%. Out of 362 males screened 22 were suffering from Diabetes mellitus (DM) i.e. prevalence of 6.07%. Whereas out of 688 females screened 28 were suffering from Diabetes mellitus (DM) i.e. prevalence of 4.06%. Prevalence of Diabetes mellitus (DM) in males was found to be maximum in age group of more than 70 years i.e. 6.97% as compare to female i.e.5.29%.Conclusions: Thus, the current study recorded high prevalence of Diabetes mellitus (DM) among rural population which should be a cause of concern for health care providers. 

Author(s):  
Alaa Noor Elahi ◽  
Fardus Almarghalani ◽  
Hussain Al-Ramadhan ◽  
Al Hassan Jalal ◽  
Haya Alnafisah ◽  
...  

Type 2 diabetes mellitus is one of the most common chronic health conditions around the world and is a major challenge to health care providers. Its incidence across the world is increasing. There is long-term affection of pancreas before symptoms start, allowing for a large window for early detection and prevention of the disease. We conducted this review using a comprehensive search of MEDLINE, PubMed, and EMBASE, January 1987, through March 2017. The following search terms were used: diabetes type 2, prevention diabetes type 2, effects of lifestyle on health, alcohol and diabetes, smoking and diabetes, preventive strategies for diabetes type 2. Our aim in this study is to understand the pathophysiology of diabetes mellitus type 2 with regards to the risk factors and how to prevent them. Diabetes mellitus type 2 is considered a preventable disease, therefore, studying its risk factors and trying to reduce them is very important. Even minor modifications in risk factors of the disease could achieve significant reduction in incidence and progression of diabetes. Weight loss, improved dietary intake, and increased exercise levels are the most important interventions that will lead to significant decrease in the occurrence of the disease.


2010 ◽  
Vol 9 (6) ◽  
pp. 148-154
Author(s):  
Yu. G. Samoilova ◽  
A. V. Enert

The diabetes mellitus of 1 type (DM1) represents a huge problem all over the world. In spite of the fact that there is a plenty of the saved up knowledge on эпидемиологии and management of the given disease in the developed countries, there is a number of mistakes and the discrepancies supposed at creation of the Federal register of a diabetes that is connected with absence of completeness of scope of all regions. With the purpose of reception of the full information on prevalence and desease DM1 among children and teenagers, for duly maintenance sick DM1 necessary quantity of insulin and means of self-checking and as with the purpose of updating of data of the Federal register there was a necessity to estimate an epidemiological situation on DM1 among children and teenagers of Tomsk Region. The lead analysis has shown, that growth DM1 in all age groups and especially among children of younger age is marked.


2019 ◽  
Author(s):  
Minmin Li ◽  
Tao Chen ◽  
Zhongqiu Hua ◽  
Ni Zhu ◽  
Duolao Wang ◽  
...  

Abstract Background. The concept that people with pulmonary tuberculosis are at risk of developing diabetes mellitus has been raised. However, the prevalence of diabetes mellitus in patients with pulmonary tuberculosis have not been well established. We aim to estimate the global, regional, and national prevalence of diabetes mellitus in population with pulmonary tuberculosis. Methods. In this systematic review and meta-analysis, we assessed observational studies of diabetes mellitus in people with pulmonary tuberculosis, using PubMed and Embase electronic bibliographic databases in English language, to identify articles published until August 31, 2018. We included original research studies published in a peer-reviewed journal and reported the prevalence of diabetes mellitus or had enough data to compute these estimates. Studies were excluded if they did not provide primary data or were case studies and reviews. Independent extraction of articles and collected detailed information by 2 authors using predefined questionnaire, including study quality indicators. The country-specific random-effects meta-analyses for countries with two or more available studies and a fractional response regression model to predict individual studies prevalence of diabetes mellitus in patients with pulmonary tuberculosis for countries with one or no study. The study is registered with PROSPERO, registration number CRD42018101989. Results. We identified 18042 studies, and 127 were retained for data extraction across 46 countries. The global prevalence of diabetes mellitus in patients with pulmonary tuberculosis were estimated to be 12.07% (95%CI: 10.43-14.85). The prevalence of diabetes mellitus in patients with pulmonary tuberculosis was 13.38% (95%CI: 11.16-16.05) in region of Americas, 13.34% (95%CI: 12.82-14.61) in European region, 12.68% (95%CI: 9.15-16.37) in South-East Asia, 12.56% (95%CI: 11.79-22.70) in Western Pacific region, 10.95% (95%CI: 9.04-17.83) in Eastern Mediterranean region and 7.54% (95%CI: 6.51-8.77)in African region. The country with the highest estimated prevalence of pulmonary tuberculosis combined diabetes mellitus were Mauritius (39.65%, 95%CI: 4.22-90.74). Conclusion. Our findings suggest that pulmonary tuberculosis combined diabetes mellitus is still prevalent. As such, diabetes mellitus deserves more attention from PTB health-care providers, researchers, policy makers, and stakeholders for improved detection, overall proper management, and efficient control of diabetes mellitus in people with pulmonary tuberculosis.


2000 ◽  
Vol 6 (1_suppl) ◽  
pp. 102-103 ◽  
Author(s):  
Terry Dennis ◽  
David Owens

The prevalence of diabetes mellitus is steadily increasing in Western society, with obvious implications for costs to health-care providers. A project plan to transform local care has been established in Wales to enable diabetic patients to self-manage their disease by improving education and access to information and tests locally. The plan involves the establishment of local diabetes centres providing educational resources to the patients, carers and health professionals. It envisages that the local diabetes community centres will provide all aspects of diabetic care, from diagnosis to continuing management, with the aid of modern communications technology.


2019 ◽  
Vol 15 (2) ◽  
pp. 105-110 ◽  
Author(s):  
Eric Francelino Andrade ◽  
Víviam de Oliveira Silva ◽  
Débora Ribeiro Orlando ◽  
Luciano José Pereira

Introduction: Diabetes mellitus is a metabolic disease characterized by high glycemic levels for long periods. This disease has a high prevalence in the world population, being currently observed an increase in its incidence. This fact is mainly due to the sedentary lifestyle and hypercaloric diets. Non-pharmacological interventions for glycemic control include exercise, which promotes changes in skeletal muscle and adipocytes. Thus, increased glucose uptake by skeletal muscle and decreased insulin resistance through modulating adipocytes are the main factors that improve glycemic control against diabetes. Conclusion: It was sought to elucidate mechanisms involved in the improvement of glycemic control in diabetics in front of the exercise.


2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Johannes C. Fischer ◽  
Albrecht G. Schmidt ◽  
Edwin Bölke ◽  
Verena Keitel ◽  
Torsten Feldt ◽  
...  

Abstract Background COVID-19 infection is a major threat to patients and health care providers around the world. One solution is the vaccination against SARS-CoV-2. Methods We performed a comprehensive query of the latest publications on the prevention of viral infections including the recent vaccination program and its side effects. Results The situation is evolving rapidly and there is no reasonable alternative to population-scale vaccination programs as currently enrolled. Conclusion Therefore, regulatory authorities should consider supplementing their conventional mandate of post-approval pharmacovigilance, which is based on the collection, assessment, and regulatory response to emerging safety findings.


2021 ◽  
Vol 36 (3) ◽  
pp. 125-126
Author(s):  
Chris Alderman

People from developed countries around the world now routinely live into their 80s and beyond, and this is associated with a range of medical and societal challenges that must be addressed. It is relatively rare to encounter older people who are not affected by one or more chronic diseases, including conditions such as osteoarthritis, gastroesophageal reflux disease (GERD), hypertension, and depression. The concurrence of a number of medical and/or psychiatric conditions in the same patient has come to be referred to as multimorbidity, and it is a particularly familiar phenomenon observed by health care providers in settings such as the Emergency Department (ED), primary care practice, and long-term care facilities. Given that life expectancy continues to increase, and that there is considerable further investment in research for the development of new treatments, which will achieve adoption and be promoted to consumers, it is clear that multimorbidity is likely to be a driver for problems arising from medications that are vigorously promoted to consumers.


2018 ◽  
Vol 6 (2) ◽  
pp. 340-343 ◽  
Author(s):  
Salih Eker

BACKGROUND: Diabetes mellitus (DM) is one of the most prevalent diseases all over the world. Prevalence of DM in Turkey is 13.7%. Depression is another condition which has a high prevalence. All over the world, an estimated 300 million people of all ages suffer from depression. The relevance between depression and DM is a well - known condition.AIM: We aimed in this study to find out the prevalence of depression symptoms for DM in an attempt to better manage the disease.METHODS: We preferred the Beck Depression Index (BDI) to evaluate the depression symptoms.RESULTS: The number of patients introduced the study were 171 (101 (59.1%) female). As a results of BDI 67 (39.2%) patients evaluated as normal [29 (28.7%) female], 54 (31.6%) had poor symptoms [35 (34.7%) female], 46 (26.9%) had moderate symptoms [34 (33.7%) female] and lastly only 4(2.3%) had strong symptoms 3 (3.0%) female]. So 50 (29.2%) of patients had median plus strong symptoms. There were statistically significant association between HbA1c stages and depression (P = 0.018).CONCLUSION: Being a patient with DM is a strong indicator that the patient may have a depressive disorder. So the physician who takes care patients with DM should be alert about depression, and the simplest way to accomplish is BDI.


2001 ◽  
Vol 18 (9) ◽  
pp. 768-769 ◽  
Author(s):  
C. Lionis ◽  
M. Bathianaki ◽  
N. Antonakis ◽  
S. Papavasiliou ◽  
A. Philalithis

Sign in / Sign up

Export Citation Format

Share Document